General Information of the Protein
Protein ID
PT04927
Protein Name
Potassium voltage-gated channel subfamily KQT member 1
Secondarily
Protein Name
IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1
KQT-like 1
Voltage-gated potassium channel subunit Kv7.1
Gene Name
KCNQ1
Secondarily
Gene Name
KCNA8
KCNA9
KVLQT1
Sequence
MAAASSPPRAERKRWGWGRLPGARRGSAGLAKKCPFSLELAEGGPAGGALYAPIAPGAPGPAPPASPAAPAAPPVASDLGPRPPVSLDPRVSIYSTRRPVLARTHVQGRVYNFLERPTGWKCFVYHFAVFLIVLVCLIFSVLSTIEQYAALATGTLFWMEIVLVVFFGTEYVVRLWSAGCRSKYVGLWGRLRFARKPISIIDLIVVVASMVVLCVGSKGQVFATSAIRGIRFLQILRMLHVDRQGGTWRLLGSVVFIHRQELITTLYIGFLGLIFSSYFVYLAEKDAVNESGRVEFGSYADALWWGVVTVTTIGYGDKVPQTWVGKTIASCFSVFAISFFALPAGILGSGFALKVQQKQRQKHFNRQIPAAASLIQTAWRCYAAENPDSSTWKIYIRKAPRSHTLLSPSPKPKKSVVVKKKKFKLDKDNGVTPGEKMLTVPHITCDPPEERRLDHFSVDGYDSSVRKSPTLLEVSMPHFMRTNSFAEDLDLEGETLLTPITHISQLREHHRATIKVIRRMQYFVAKKKFQQARKPYDVRDVIEQYSQGHLNLMVRIKELQRRLDQSIGKPSLFISVSEKSKDRGSNTIGARLNRVEDKVTQLDQRLALITDMLHQLLSLHGGSTPGSGGPPREGGAHITQPCGSGGSVDPELFLPSNTLPTYEQLTVPRRGPDEGS
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Ion channel
>
Voltage-gated ion channel
>
Potassium channels
>
Voltage-gated potassium channel
Function
Potassium channel that plays an important role in a number of tissues, including heart, inner ear, stomach and colon (PubMed:10646604, PubMed:25441029). Associates with KCNE beta subunits that modulates current kinetics (PubMed:9312006, PubMed:9108097, PubMed:8900283, PubMed:10646604, PubMed:11101505, PubMed:19687231). Induces a voltage-dependent current by rapidly activating and slowly deactivating potassium-selective outward current (PubMed:9312006, PubMed:9108097, PubMed:8900283, PubMed:10646604, PubMed:11101505, PubMed:25441029). Promotes also a delayed voltage activated potassium current showing outward rectification characteristic (By similarity). During beta-adrenergic receptor stimulation participates in cardiac repolarization by associating with KCNE1 to form the I(Ks) cardiac potassium current that increases the amplitude and slows down the activation kinetics of outward potassium current I(Ks) (By similarity) (PubMed:9312006, PubMed:9108097, PubMed:8900283, PubMed:10646604, PubMed:11101505). Muscarinic agonist oxotremorine-M strongly suppresses KCNQ1/KCNE1 current (PubMed:10713961). When associated with KCNE3, forms the potassium channel that is important for cyclic AMP-stimulated intestinal secretion of chloride ions (PubMed:10646604). This interaction with KCNE3 is reduced by 17beta-estradiol, resulting in the reduction of currents (By similarity). During conditions of increased substrate load, maintains the driving force for proximal tubular and intestinal sodium ions absorption, gastric acid secretion, and cAMP-induced jejunal chloride ions secretion (By similarity). Allows the provision of potassium ions to the luminal membrane of the secretory canaliculus in the resting state as well as during stimulated acid secretion (By similarity). When associated with KCNE2, forms a heterooligomer complex leading to currents with an apparently instantaneous activation, a rapid deactivation process and a linear current-voltage relationship and decreases the amplitude of the outward current (PubMed:11101505). When associated with KCNE4, inhibits voltage-gated potassium channel activity (PubMed:19687231). When associated with KCNE5, this complex only conducts current upon strong and continued depolarization (PubMed:12324418). Also forms a heterotetramer with KCNQ5; has a voltage-gated potassium channel activity (PubMed:24855057). Binds with phosphatidylinositol 4,5-bisphosphate (PubMed:25037568). KCNQ1-KCNE2 channel associates with Na(+)-coupled myo-inositol symporter in the apical membrane of choroid plexus epithelium and regulates the myo-inositol gradient between blood and cerebrospinal fluid with an impact on neuron excitability.
    Show/Hide
Uniprot ID
Primary ID:
P51787

Secondarily ID:
O00347
O60607
O94787
Q14D14
Q7Z6G9
Q92960
Q9UMN8
Q9UMN9
    Show/Hide
Ensembl ID
ENSG00000053918
HGNC ID
HGNC:6294
Subcellular Location
Cell membrane
Cytoplasmic vesicle membrane
Early endosome
Membrane raft
Endoplasmic reticulum
Basolateral cell membrane
Apical cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Compound ID Compound Name Compound Formula
CP0165878
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C23H25N3O4S2
 1
1
EC50 = 260 nM
   TI
   LI
   LO
   TS
CP0423690
(2R)-1-(4-chlorophenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C22H22ClN3O4S2
 1
1
EC50 = 420 nM
   TI
   LI
   LO
   TS
CP0423684
N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-4-(4-methylphenyl)sulfonylthiomorpholine-3-carboxamide
   Show/Hide
C22H23N3O4S3
 1
1
EC50 = 600 nM
   TI
   LI
   LO
   TS
CP0433948
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(4-propylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C25H29N3O4S2
 1
1
EC50 = 700 nM
   TI
   LI
   LO
   TS
CP0453130
(2R)-1-(2-chlorophenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C22H22ClN3O4S2
 1
1
EC50 = 730 nM
   TI
   LI
   LO
   TS
CP0437847
(2R)-1-(1,3-benzodioxol-5-ylsulfonyl)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H23N3O6S2
 1
1
EC50 = 780 nM
   TI
   LI
   LO
   TS
CP0423680
(2R)-1-(3-methoxyphenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H25N3O5S2
 1
1
EC50 = 810 nM
   TI
   LI
   LO
   TS
CP0487671
(2R)-1-(3-cyanophenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H22N4O4S2
 1
1
EC50 = 880 nM
   TI
   LI
   LO
   TS
CP0423679
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(3-methylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C23H25N3O4S2
 1
1
EC50 = 890 nM
   TI
   LI
   LO
   TS
CP0433944
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-[3-(trifluoromethyl)phenyl]sulfonylpiperidine-2-carboxamide
   Show/Hide
C23H22F3N3O4S2
 1
1
EC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0453129
(2R)-1-(4-fluorophenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C22H22FN3O4S2
 1
1
EC50 = 1030 nM
   TI
   LI
   LO
   TS
CP0523380
(2R)-1-(3-fluorophenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C22H22FN3O4S2
 1
1
EC50 = 1160 nM
   TI
   LI
   LO
   TS
CP0433946
(2R)-N-[4-(1-benzofuran-5-yl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C24H23N3O4S2
 1
1
EC50 = 1320 nM
   TI
   LI
   LO
   TS
CP0423682
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-pyridin-3-ylsulfonylpiperidine-2-carboxamide
   Show/Hide
C21H22N4O4S2
 1
1
EC50 = 1360 nM
   TI
   LI
   LO
   TS
CP0423686
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(2-methylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C23H25N3O4S2
 1
1
EC50 = 1380 nM
   TI
   LI
   LO
   TS
CP0379106
(2R)-1-(3-chlorophenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C22H22ClN3O4S2
 1
1
EC50 = 1410 nM
   TI
   LI
   LO
   TS
CP0429461
(2R)-1-(benzenesulfonyl)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C22H23N3O4S2
 1
1
EC50 = 1470 nM
   TI
   LI
   LO
   TS
CP0379105
(2R)-1-(4-cyanophenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H22N4O4S2
 1
1
EC50 = 1630 nM
   TI
   LI
   LO
   TS
CP0188691
1-(benzenesulfonyl)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C22H23N3O4S2
 1
1
EC50 = 1690 nM
   TI
   LI
   LO
   TS
CP0423689
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-[4-(trifluoromethyl)phenyl]sulfonylpiperidine-2-carboxamide
   Show/Hide
C23H22F3N3O4S2
 1
1
EC50 = 1710 nM
   TI
   LI
   LO
   TS
CP0453126
(2R)-1-(2-methoxyphenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H25N3O5S2
 1
1
EC50 = 1780 nM
   TI
   LI
   LO
   TS
CP0423687
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(4-propan-2-ylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C25H29N3O4S2
 1
1
EC50 = 2590 nM
   TI
   LI
   LO
   TS
CP0433949
N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylpyrrolidine-2-carboxamide
   Show/Hide
C22H23N3O4S2
 1
1
EC50 = 2860 nM
   TI
   LI
   LO
   TS
CP0483283
N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-4-(4-methylphenyl)sulfonylmorpholine-3-carboxamide
   Show/Hide
C22H23N3O5S2
 1
1
EC50 = 4380 nM
   TI
   LI
   LO
   TS
CP0423688
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-[2-(trifluoromethyl)phenyl]sulfonylpiperidine-2-carboxamide
   Show/Hide
C23H22F3N3O4S2
 1
1
EC50 = 4740 nM
   TI
   LI
   LO
   TS
CP0379109
(2R)-1-(3-fluorobenzoyl)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H22FN3O3S
 1
1
EC50 = 6130 nM
   TI
   LI
   LO
   TS
CP0438914
(2R)-1-isoquinolin-1-ylsulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C25H24N4O4S2
 1
1
EC50 = 7970 nM
   TI
   LI
   LO
   TS
CP0423692
(2R)-1-benzoyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H23N3O3S
 1
1
EC50 = 8160 nM
   TI
   LI
   LO
   TS
CP0514751
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-2-[(4-methylphenyl)sulfonylamino]propanamide
   Show/Hide
C20H21N3O4S2
 1
1
EC50 = 12900 nM
   TI
   LI
   LO
   TS
CP0437850
(2R)-N-[5-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C23H25N3O4S2
 1
1
EC50 = 27400 nM
   TI
   LI
   LO
   TS
CP0379108
(2R)-1-(2-chloro-4-fluorophenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C22H21ClFN3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0379110
N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-3-[(4-methylphenyl)sulfonylamino]propanamide
   Show/Hide
C20H21N3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0379111
(2R)-N-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C22H22FN3O3S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0423681
(2R)-1-(5-chloro-2-fluorophenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C22H21ClFN3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0423683
N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylazetidine-2-carboxamide
   Show/Hide
C21H21N3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0423685
(2R)-N-[5-(1-benzofuran-5-yl)-1,3,4-thiadiazol-2-yl]-1-(4-methylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C23H22N4O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0423691
(2R)-1-(3-fluoro-2-methylphenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H24FN3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0433945
(2R)-N-(1,3-benzothiazol-2-yl)-1-(4-methylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C20H21N3O3S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0433947
(2R)-N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-1-(4-methylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C22H24N4O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0437848
(2R)-1-[(4-chlorophenyl)methylsulfonyl]-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H24ClN3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0437849
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-3,3-dimethyl-2-[(4-methylphenyl)sulfonylamino]butanamide
   Show/Hide
C23H27N3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0438915
(3S)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylpiperidine-3-carboxamide
   Show/Hide
C23H25N3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0438916
(2R)-1-(4-chlorophenyl)sulfonyl-N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C21H21ClN4O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0453124
(2S)-1-(benzenesulfonyl)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C22H23N3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0480480
(2R)-1-(2,3-dichlorophenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C22H21Cl2N3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0480484
N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylazepane-2-carboxamide
   Show/Hide
C24H27N3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0483280
(2R)-1-(4-methylphenyl)sulfonyl-N-[4-(4-methylphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H25N3O3S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0483281
(2R)-1-(4-methylphenyl)sulfonyl-N-[4-(4-nitrophenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C22H22N4O5S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0483282
(2R)-1-(2-cyanophenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H22N4O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0487673
(2R)-N-[5-(1-benzofuran-5-yl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C24H23N3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0514747
(2R)-1-[(2-chlorophenyl)methylsulfonyl]-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H24ClN3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0523379
(2R)-1-(4-tert-butylphenyl)sulfonyl-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C26H31N3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0526928
(2R)-1-(4-methylphenyl)sulfonyl-N-(4-phenyl-1,3-thiazol-2-yl)piperidine-2-carboxamide
   Show/Hide
C22H23N3O3S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0526972
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(1-methylimidazol-4-yl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C20H23N5O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0526973
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(2-methylpyridin-3-yl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C22H24N4O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0526975
(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-3-methyl-2-[(4-methylphenyl)sulfonylamino]butanamide
   Show/Hide
C22H25N3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0526977
(2R)-1-(4-methylphenyl)sulfonyl-N-(1,3-thiazol-2-yl)piperidine-2-carboxamide
   Show/Hide
C16H19N3O3S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0527019
(2R)-1-(4-methylphenyl)sulfonyl-N-[4-[4-(trifluoromethoxy)phenyl]-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C23H22F3N3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0531931
(2R)-1-(2-methoxybenzoyl)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C24H25N3O4S
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0531933
N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylpiperazine-2-carboxamide
   Show/Hide
C22H24N4O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0531934
(2R)-1-(4-methylphenyl)sulfonyl-N-[4-(4-propan-2-ylphenyl)-1,3-thiazol-2-yl]piperidine-2-carboxamide
   Show/Hide
C25H29N3O3S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0531936
(2R)-N-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylpiperidine-2-carboxamide
   Show/Hide
C22H22ClN3O3S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0870546
N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-3-carboxamide
   Show/Hide
C23H25N3O4S2
 1
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
CP0010522
(2S)-2-phenyl-N-(2-pyrrolidin-1-ylphenyl)butanamide
   Show/Hide
C20H24N2O
 1
1
IC50 = 2920 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Voltage-gated potassium channel Kv7.1 (KCNQ1) )
Target Type Successful Target
Disease 1 Target-related Disease  1
1 Hypertension [ICD-11: BA00-BA04]
Approved Drug(s) 1 Approved Drug  1
1 Indapamide Approved
Hypertension